Acrivon Therapeutics, Inc. — All Filings
291 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001346824-26-000081 | Mar 23, 2026 | — |
| S-8 | S-8 | 0001193125-26-115150 | Mar 19, 2026 | — |
| 8-K | 8-K | 0001193125-26-115139 | Mar 19, 2026 | — |
| 10-K | 10-K | 0001193125-26-115123 | Mar 19, 2026 | Dec 31, 2025 |
| 4 | FORM 4 | 0000905148-26-001121 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001120 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001119 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001118 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001117 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001116 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001115 | Mar 3, 2026 | Mar 1, 2026 |
| 8-K | 8-K | 0001193125-26-085516 | Mar 2, 2026 | Feb 25, 2026 |
| 8-K | 8-K | 0001193125-26-079500 | Feb 27, 2026 | — |
| 4 | FORM 4 | 0000905148-26-001010 | Feb 24, 2026 | Feb 21, 2026 |
| 4 | FORM 4 | 0000905148-26-000939 | Feb 18, 2026 | Feb 14, 2026 |
| 4 | FORM 4 | 0000905148-26-000937 | Feb 18, 2026 | Feb 14, 2026 |
| 4 | FORM 4 | 0000905148-26-000936 | Feb 18, 2026 | Feb 14, 2026 |
| 4 | FORM 4 | 0000905148-26-000935 | Feb 18, 2026 | Feb 14, 2026 |
| 4 | FORM 4 | 0000905148-26-000934 | Feb 18, 2026 | Feb 14, 2026 |
| 4 | — | 0000905148-26-000281 | Jan 21, 2026 | Jan 17, 2026 |
| 4 | — | 0000905148-26-000226 | Jan 16, 2026 | Jan 14, 2026 |
| 4 | — | 0000905148-26-000225 | Jan 16, 2026 | Jan 14, 2026 |
| 4 | — | 0000905148-26-000212 | Jan 15, 2026 | Jan 13, 2026 |
| 8-K | 8-K | 0001193125-26-007077 | Jan 8, 2026 | — |
| 8-K | 8-K | 0001193125-26-007007 | Jan 8, 2026 | — |
| 4 | — | 0000905148-25-004179 | Nov 25, 2025 | Nov 21, 2025 |
| SCHEDULE 13G | — | 0001104659-25-115063 | Nov 21, 2025 | — |
| 4 | — | 0000905148-25-004131 | Nov 18, 2025 | Nov 14, 2025 |
| 4 | — | 0000905148-25-004130 | Nov 18, 2025 | Nov 14, 2025 |
| 4 | — | 0000905148-25-004129 | Nov 18, 2025 | Nov 14, 2025 |
| 4 | — | 0000905148-25-004128 | Nov 18, 2025 | Nov 14, 2025 |
| 4 | — | 0000905148-25-004127 | Nov 18, 2025 | Nov 14, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-112501 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-280215 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-280172 | Nov 13, 2025 | — |
| 4 | — | 0000905148-25-003637 | Oct 21, 2025 | Oct 17, 2025 |
| 4 | — | 0000905148-25-003507 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | — | 0000905148-25-003506 | Oct 3, 2025 | Oct 1, 2025 |
| 8-K | 8-K | 0001193125-25-197250 | Sep 5, 2025 | — |
| 4 | — | 0000905148-25-003121 | Aug 25, 2025 | Aug 21, 2025 |
| 4 | — | 0000905148-25-003043 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0000905148-25-003042 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0000905148-25-003041 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0000905148-25-003040 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0000905148-25-003039 | Aug 18, 2025 | Aug 14, 2025 |
| 10-Q | 10-Q | 0000950170-25-108054 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001193125-25-179834 | Aug 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001875620-25-000020 | Aug 13, 2025 | — |
| 4 | — | 0000905148-25-002732 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | — | 0000905148-25-002493 | Jul 21, 2025 | Jul 17, 2025 |